Product Information
PRAMIPEXOLE 0.25 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0452 per EA under NDC 50228012710. Its NADAC has been published 276 times since Jun 23, 2021.
FDA first approved this application on Oct 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228012710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203855FDA Approved
10/28/2014
TE Code
AB
On Market Since
10/29/2014
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE 0.25 MG TABLET has been published 276 times since Jun 23, 2021, and over the history we have for it it has declined 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0452 per EA |
|---|---|
| All-time high | $0.0583 (Dec 15, 2021) |
| All-time low | $0.0364 (Nov 20, 2024) |
| 52-week high | $0.0473 |
| 52-week low | $0.0452 |
| Median price | $0.0490 |
| Average price | $0.0492 |
| Largest weekly change | +24.4% (Jun 19, 2024) |
| Weeks tracked | 276 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pramipexole Dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonergot Dopamine Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE 0.25 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.0452 per EA (NDC 50228012710), effective Sep 30, 2026.
How has the price of PRAMIPEXOLE 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE 0.25 MG TABLET has declined 2.7%. It has been tracked across 276 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE 0.25 MG TABLET?
Since Jun 23, 2021, the NADAC for PRAMIPEXOLE 0.25 MG TABLET has ranged from a low of $0.0364 (Nov 20, 2024) to a high of $0.0583 (Dec 15, 2021), with a median of $0.0490 per EA.
Are there cheaper alternatives to PRAMIPEXOLE 0.25 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAMIPEXOLE 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAMIPEXOLE 0.25 MG TABLET?
PRAMIPEXOLE 0.25 MG TABLET (NDC 50228012710) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.